Clinical Trials Browser

Phase 1 × Advanced Malignant Solid Tumor × Immune Checkpoint Inhibitors × Clear all

NCT04864379 2021-04-28

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Malignant Solid Tumor